[
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY): One of the High Growth Dividend Paying Stocks to Invest in",
    "summary": "We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other profitable dividend stocks. Amid growing concerns about economic growth and President Trump’s tariffs, investors have been seeking safer investment […]",
    "url": "https://finnhub.io/api/news?id=f9c399c7ebb8eeeb9356657c778f3378424348589d36afbf8372abbc9ff23b84",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744229962,
      "headline": "Eli Lilly and Company (LLY): One of the High Growth Dividend Paying Stocks to Invest in",
      "id": 133841309,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other profitable dividend stocks. Amid growing concerns about economic growth and President Trump’s tariffs, investors have been seeking safer investment […]",
      "url": "https://finnhub.io/api/news?id=f9c399c7ebb8eeeb9356657c778f3378424348589d36afbf8372abbc9ff23b84"
    }
  },
  {
    "ts": null,
    "headline": "These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth",
    "summary": "Netflix and DoorDash are two of the seven best stocks where investors can find magnificent profit growth prospects.  More than 70% of analysts covering Netflix have buy or overweight ratings on the video streaming service.  The consensus estimate for 2025 earnings is $24.69, a 25% increase from last year.",
    "url": "https://finnhub.io/api/news?id=d6c2d8311e80e499363328e31d436387786100b5a8afd235145a0b634ed99eca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744220181,
      "headline": "These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth",
      "id": 133841310,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Netflix and DoorDash are two of the seven best stocks where investors can find magnificent profit growth prospects.  More than 70% of analysts covering Netflix have buy or overweight ratings on the video streaming service.  The consensus estimate for 2025 earnings is $24.69, a 25% increase from last year.",
      "url": "https://finnhub.io/api/news?id=d6c2d8311e80e499363328e31d436387786100b5a8afd235145a0b634ed99eca"
    }
  },
  {
    "ts": null,
    "headline": "Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out",
    "summary": "Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.",
    "url": "https://finnhub.io/api/news?id=d8c8bdc63573f8d0446b53adc6c660707a5a38387c201d6d905b0dc1c387ec40",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744214397,
      "headline": "Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out",
      "id": 133838600,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2046288144/image_2046288144.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.",
      "url": "https://finnhub.io/api/news?id=d8c8bdc63573f8d0446b53adc6c660707a5a38387c201d6d905b0dc1c387ec40"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Aren’t a Shelter From the Tariff Storm",
    "summary": "Healthcare Stocks Aren’t a Shelter From the Tariff Storm",
    "url": "https://finnhub.io/api/news?id=c2f5378c0fa99031c67406c77a735a101dc0f07920b0126f65bd825239b67142",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744212120,
      "headline": "Healthcare Stocks Aren’t a Shelter From the Tariff Storm",
      "id": 133844746,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Healthcare Stocks Aren’t a Shelter From the Tariff Storm",
      "url": "https://finnhub.io/api/news?id=c2f5378c0fa99031c67406c77a735a101dc0f07920b0126f65bd825239b67142"
    }
  },
  {
    "ts": null,
    "headline": "Delta, Walmart, pharmaceutical stocks: Market Minute",
    "summary": "Catalysts host Madison Mills goes over some of the top stories of the day on this segment of Market Minute. Delta Air Lines (DAL) cut its full-year guidance as uncertainty around tariffs weighs on bookings. Walmart (WMT) walks back its first quarter profit guidance, citing tariff risks. Pharmaceutical stocks, including Pfizer (PFE), Novo Nordisk (NVO), and Eli Lilly (LLY), are under pressure after President Trump announced that there may be pharmaceutical tariffs underway. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=bcf1238ab8a7e92266b2bc74587d6db7c852069139c5954bb86b8e0922c2e170",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744211738,
      "headline": "Delta, Walmart, pharmaceutical stocks: Market Minute",
      "id": 133841311,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Catalysts host Madison Mills goes over some of the top stories of the day on this segment of Market Minute. Delta Air Lines (DAL) cut its full-year guidance as uncertainty around tariffs weighs on bookings. Walmart (WMT) walks back its first quarter profit guidance, citing tariff risks. Pharmaceutical stocks, including Pfizer (PFE), Novo Nordisk (NVO), and Eli Lilly (LLY), are under pressure after President Trump announced that there may be pharmaceutical tariffs underway. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=bcf1238ab8a7e92266b2bc74587d6db7c852069139c5954bb86b8e0922c2e170"
    }
  },
  {
    "ts": null,
    "headline": "Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today",
    "summary": "Might the tariff risk for pharmaceutical stocks be less than you think?",
    "url": "https://finnhub.io/api/news?id=3c7ccc43120557e2b324144e3b4456cdd5d4c1bbafd960991169ebf585195c92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744211481,
      "headline": "Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today",
      "id": 133841312,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Might the tariff risk for pharmaceutical stocks be less than you think?",
      "url": "https://finnhub.io/api/news?id=3c7ccc43120557e2b324144e3b4456cdd5d4c1bbafd960991169ebf585195c92"
    }
  },
  {
    "ts": null,
    "headline": "Apple, Alibaba, drugmaker stocks: Trending Tickers",
    "summary": "Catalysts host Madison Mills and Trader Talk podcast host Kenny Polcari take a look at some of the day's top trending stocks. Apple (AAPL) is in focus after Microsoft (MSFT) replaced Apple as the most valuable company. Alibaba (BABA) reverses earlier gains after US tariffs went into effect. Drugmaker stocks, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), are falling after President Trump announced that pharmaceutical tariffs may be on the way. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
    "url": "https://finnhub.io/api/news?id=5e8907580bc972eecbf469c17b1947cb67ed4fa990d7520a5aa0efcf38010c8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744209802,
      "headline": "Apple, Alibaba, drugmaker stocks: Trending Tickers",
      "id": 133841313,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Catalysts host Madison Mills and Trader Talk podcast host Kenny Polcari take a look at some of the day's top trending stocks. Apple (AAPL) is in focus after Microsoft (MSFT) replaced Apple as the most valuable company. Alibaba (BABA) reverses earlier gains after US tariffs went into effect. Drugmaker stocks, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), are falling after President Trump announced that pharmaceutical tariffs may be on the way. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",
      "url": "https://finnhub.io/api/news?id=5e8907580bc972eecbf469c17b1947cb67ed4fa990d7520a5aa0efcf38010c8e"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Company (LLY): Among Defensive Stocks Billionaire Ken Fisher Is Betting On",
    "summary": "We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Eli Lilly & Company (NYSE:LLY) stands against other defensive stocks Billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher […]",
    "url": "https://finnhub.io/api/news?id=8edbdc83e7ad1e376bf56bdc09898ab8451c0dfc54f591488c75ead54991ca8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744208940,
      "headline": "Eli Lilly & Company (LLY): Among Defensive Stocks Billionaire Ken Fisher Is Betting On",
      "id": 133841314,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Eli Lilly & Company (NYSE:LLY) stands against other defensive stocks Billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher […]",
      "url": "https://finnhub.io/api/news?id=8edbdc83e7ad1e376bf56bdc09898ab8451c0dfc54f591488c75ead54991ca8e"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Shares Reverse Losses After Tariff Pause",
    "summary": "By Katherine Hamilton Shares of pharmaceutical companies turned around after President Trump said there would be a 90-day pause on tariffs. Shares of drug companies including AbbVie, Eli...",
    "url": "https://finnhub.io/api/news?id=13f496e3dd5a6823664ad90500ad1f89594142b96583d4032c96f4f76519fd2a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744208348,
      "headline": "Pharma Shares Reverse Losses After Tariff Pause",
      "id": 133838125,
      "image": "",
      "related": "LLY",
      "source": "Finnhub",
      "summary": "By Katherine Hamilton Shares of pharmaceutical companies turned around after President Trump said there would be a 90-day pause on tariffs. Shares of drug companies including AbbVie, Eli...",
      "url": "https://finnhub.io/api/news?id=13f496e3dd5a6823664ad90500ad1f89594142b96583d4032c96f4f76519fd2a"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?",
    "summary": "As everyone who follows equity markets knows, stocks are feeling the heat from President Donald Trump's macroeconomic policies.  On April 3, the president announced sweeping tariffs on goods imported into the U.S. from basically every country on planet Earth.  One of them is the pharmaceutical industry.",
    "url": "https://finnhub.io/api/news?id=085892457b07a6c408777e540ac21acbff20e0d2a77514cb74313553f566c5dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744208100,
      "headline": "Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?",
      "id": 133828247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "As everyone who follows equity markets knows, stocks are feeling the heat from President Donald Trump's macroeconomic policies.  On April 3, the president announced sweeping tariffs on goods imported into the U.S. from basically every country on planet Earth.  One of them is the pharmaceutical industry.",
      "url": "https://finnhub.io/api/news?id=085892457b07a6c408777e540ac21acbff20e0d2a77514cb74313553f566c5dd"
    }
  },
  {
    "ts": null,
    "headline": "Trump says pharmaceutical tariffs may be coming: What to know",
    "summary": "Drugmaker stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that he may impose tariffs on pharmaceutical imports. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Morning Brief to break down the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=a04ba988dddb39f80fffc7912b11ca46a589bf0f30c8ab29645f4be12e91d0bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744207917,
      "headline": "Trump says pharmaceutical tariffs may be coming: What to know",
      "id": 133828249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Drugmaker stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that he may impose tariffs on pharmaceutical imports. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Morning Brief to break down the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=a04ba988dddb39f80fffc7912b11ca46a589bf0f30c8ab29645f4be12e91d0bb"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports",
    "summary": "Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take direct aim at drug imports.",
    "url": "https://finnhub.io/api/news?id=96d7557efd7589ea4007ac05e728527084c4cade1115fc3899b1dfe3df9ca456",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744207584,
      "headline": "Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports",
      "id": 133828250,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take direct aim at drug imports.",
      "url": "https://finnhub.io/api/news?id=96d7557efd7589ea4007ac05e728527084c4cade1115fc3899b1dfe3df9ca456"
    }
  },
  {
    "ts": null,
    "headline": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
    "summary": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary.  History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market.  To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).",
    "url": "https://finnhub.io/api/news?id=e2ae07b456f7d441e163f9ffa83e82d935c906f5a457afd4cda51092bf90c836",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744207200,
      "headline": "5 Top Growth Stocks to Buy in the Stock Market Sell-Off",
      "id": 133828252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary.  History tells us that equities tend to experience strong runs following downturns, so it's worth putting money into excellent companies that are being dragged down with along with the broader market.  To that end, let's consider five excellent growth-oriented companies to invest in on the dip: Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Vertex Pharmaceuticals (NASDAQ: VRTX), Intuitive Surgical (NASDAQ: ISRG), and Shopify (NASDAQ: SHOP).",
      "url": "https://finnhub.io/api/news?id=e2ae07b456f7d441e163f9ffa83e82d935c906f5a457afd4cda51092bf90c836"
    }
  },
  {
    "ts": null,
    "headline": "Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance",
    "summary": "Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.",
    "url": "https://finnhub.io/api/news?id=f60bf3783e6d4e1be998a8c5caa1620cc3c372e658be10de626af516903d2ddd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744207069,
      "headline": "Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance",
      "id": 133828228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.",
      "url": "https://finnhub.io/api/news?id=f60bf3783e6d4e1be998a8c5caa1620cc3c372e658be10de626af516903d2ddd"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs",
    "summary": "Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, signaling the industry could be next in line amid a trade war that is causing market turmoil.  AbbVie, Eli Lilly, Johnson & Johnson, Merck and Pfizer all fell at least 2% Wednesday morning.  Denmark's Novo Nordisk, Switzerland's Novartis and the U.K.'s AstraZeneca and GSK also fell 2% or more in the U.S.",
    "url": "https://finnhub.io/api/news?id=4ad9c1d7fea3deeec7d2b3a280135f38198b941591a33ba2179d1043ce0de99c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744206677,
      "headline": "Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs",
      "id": 133828256,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, signaling the industry could be next in line amid a trade war that is causing market turmoil.  AbbVie, Eli Lilly, Johnson & Johnson, Merck and Pfizer all fell at least 2% Wednesday morning.  Denmark's Novo Nordisk, Switzerland's Novartis and the U.K.'s AstraZeneca and GSK also fell 2% or more in the U.S.",
      "url": "https://finnhub.io/api/news?id=4ad9c1d7fea3deeec7d2b3a280135f38198b941591a33ba2179d1043ce0de99c"
    }
  },
  {
    "ts": null,
    "headline": "AMD downgraded, Dollar General upgraded: Wall Street’s top analyst calls",
    "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Melius Research upgraded Dollar General (DG) to Buy from Hold with a $110 price target. While the company had its own “self-inflicted” challenges and competitive challenges over the last 12 months, the firm believes it likely will benefit from a worsening macro environment and a lack of tariff exposure",
    "url": "https://finnhub.io/api/news?id=a70ed3214f5d41c559cc777cc0adaab5bdbc4cd3f3eb0c728f6bfb0168534832",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744205720,
      "headline": "AMD downgraded, Dollar General upgraded: Wall Street’s top analyst calls",
      "id": 133828257,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Melius Research upgraded Dollar General (DG) to Buy from Hold with a $110 price target. While the company had its own “self-inflicted” challenges and competitive challenges over the last 12 months, the firm believes it likely will benefit from a worsening macro environment and a lack of tariff exposure",
      "url": "https://finnhub.io/api/news?id=a70ed3214f5d41c559cc777cc0adaab5bdbc4cd3f3eb0c728f6bfb0168534832"
    }
  },
  {
    "ts": null,
    "headline": "Why drug stocks are no longer a safe haven from the stock market’s turmoil",
    "summary": "Why drug stocks are no longer a safe haven from the stock market’s turmoil",
    "url": "https://finnhub.io/api/news?id=239fef194b45c3e0deed88ea159536c67bcfdddecfa594d190ef5f32a420718c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744199340,
      "headline": "Why drug stocks are no longer a safe haven from the stock market’s turmoil",
      "id": 133844748,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Why drug stocks are no longer a safe haven from the stock market’s turmoil",
      "url": "https://finnhub.io/api/news?id=239fef194b45c3e0deed88ea159536c67bcfdddecfa594d190ef5f32a420718c"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs Upgrades Eli Lilly and (LLY)",
    "summary": "Goldman Sachs Upgrades Eli Lilly and (LLY)",
    "url": "https://finnhub.io/api/news?id=313b6fbf76d21bee5f00c9023c377fa988b84da7b0122b093e33ad4081a42fa0",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744157022,
      "headline": "Goldman Sachs Upgrades Eli Lilly and (LLY)",
      "id": 133810838,
      "image": "",
      "related": "LLY",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=313b6fbf76d21bee5f00c9023c377fa988b84da7b0122b093e33ad4081a42fa0"
    }
  }
]